Fitzpatrick skin type is a risk-stratification tool, not an automatic approval or exclusion. Types I, II, and lighter III generally have the lowest risk of pigmentary complications from high-energy CO₂ or Er:YAG resurfacing. Types IV–VI can still be treated, but require more conservative settings, careful counseling, and often a test spot—particularly when ablative treatment is being considered.
The darker the patient’s phototype, the greater the risk of post-inflammatory hyperpigmentation, prolonged erythema, and delayed hypopigmentation. For Fitzpatrick IV–VI, suitability depends on balancing the indication and expected benefit against these risks, not simply selecting a different laser.
Start With Phototype and Pigmentary Risk
Confirm the Fitzpatrick classification
The Fitzpatrick scale estimates epidermal melanin content and the skin’s tendency to burn or tan after ultraviolet exposure, from Type I through Type VI.
Classification should be based on the patient’s natural, relatively untanned skin and supported by clinical history. Ethnicity alone should not determine the phototype; patients of any ancestry may fall across several Fitzpatrick categories.
Assess more than the skin type
Ask about prior post-inflammatory hyperpigmentation (PIH), hypopigmentation, keloid or abnormal scar formation, prolonged erythema, and reactions to previous procedures.
A history of PIH or poor wound healing can increase risk even when the patient has a relatively light Fitzpatrick classification. Recent tanning, active inflammation, dermatitis, infection, or uncontrolled photosensitivity should also prompt postponement or reconsideration.
Match risk to the treatment indication
High-energy ablative resurfacing may be more appropriate when the expected benefit is substantial, such as severe rhytids or significant scarring.
For mild photodamage, the potential benefit may not justify the pigmentary and healing risks of aggressive CO₂ or Er:YAG treatment, particularly in darker phototypes.
How Suitability Changes by Fitzpatrick Type
Types I and II
Fitzpatrick I–II patients are generally the most amenable to high-energy CO₂ resurfacing and are also strong candidates for Er:YAG treatment.
Their lower epidermal melanin content reduces competitive absorption of laser energy and the risk of PIH. They can still experience postoperative erythema, delayed healing, infection, and scarring, so lighter skin is not risk-free.
Lighter Type III
Lighter Type III patients may be suitable for ablative resurfacing, but they should not automatically be managed like Types I–II.
The practitioner should consider tanning status, prior pigmentary reactions, treatment depth, device modality, and the patient’s ability to follow strict aftercare. Conservative treatment or fractional delivery may be more appropriate than maximal resurfacing.
Types IV–VI
Darker phototypes have a substantially higher risk of PIH, thermal injury, and persistent pigmentary alteration after ablative laser treatment.
Delayed permanent hypopigmentation is also possible and may not become apparent until many months after treatment—potentially as late as 18 months. This possibility must be included in informed consent.
Types IV–VI are therefore not an automatic contraindication, but they are higher-risk candidates who require conservative selection and parameter adjustment.
Choose the Laser and Delivery Strategy Carefully
CO₂ resurfacing
Traditional high-energy CO₂ treatment produces greater collateral thermal injury than Er:YAG treatment. That thermal effect can increase the likelihood of prolonged erythema and pigmentary change in patients with more melanin.
When CO₂ is selected for a darker phototype, practitioners should consider lower fluence, smaller spot sizes, limited passes, appropriate pulse control, and effective cooling. Fractionated delivery may reduce the area of continuous injury, but it does not eliminate pigmentary risk.
Er:YAG resurfacing
Er:YAG energy is more strongly absorbed by water, allowing precise epidermal ablation with less collateral thermal damage than traditional CO₂ resurfacing.
For this reason, Er:YAG is generally preferable when ablative resurfacing is being considered for darker skin, although it remains capable of causing PIH, hypopigmentation, and other complications. The treatment should still be conservative and individualized.
Adjust the treatment profile
For higher-risk phototypes, the goal is to minimize unnecessary thermal injury while achieving the required clinical endpoint.
Relevant adjustments may include lower fluence, longer pulse durations where appropriate, reduced density, fewer passes, and effective cooling. Exact settings must be based on the specific device, treatment area, indication, and operator’s validated protocol rather than copied across platforms.
Use Testing and Staged Treatment for Higher-Risk Patients
Perform a test spot when risk is substantial
For a darker-skinned patient with a strong indication—such as severe rhytids or scarring—a small test spot can help assess the individual’s thermal and pigmentary response.
The primary reference recommends an approximately 2 × 2 cm test spot. The response should be observed over an appropriate healing interval before treating a larger area; an immediate lack of adverse reaction does not prove that delayed pigmentary complications will not occur.
Consider fractional or lower-impact treatment
Fractional treatment can reduce the amount of skin exposed to continuous ablation and may be preferable when full-field resurfacing presents excessive risk.
It should not be described as risk-free. Density, energy, pulse characteristics, passes, and stacking all influence the degree of thermal injury and pigment disruption.
Escalate cautiously between sessions
A staged course allows the practitioner to evaluate healing, erythema, pigment changes, and patient tolerance before increasing treatment intensity.
For darker or highly reactive skin, subsequent settings should be increased only when the prior session has healed without concerning pigmentary or textural effects.
Prepare the Patient Before and After Treatment
Control ultraviolet exposure
Strict sun avoidance is essential before and after resurfacing because ultraviolet exposure can amplify melanocyte activity and increase PIH risk.
Patients should use daily broad-spectrum sunscreen and follow a prolonged sun-protection plan. Treatment timing should minimize exposure during periods of intense sunlight.
Consider pre-treatment for pigment-prone patients
Patients with darker phototypes or a previous history of PIH may benefit from a practitioner-directed topical pigment-management regimen before treatment.
The supplementary reference describes pre-treatment with topical bleaching agents for approximately 2–8 weeks in at-risk patients. This should be individualized, monitored for irritation, and stopped or modified according to the practitioner’s protocol.
Set expectations about visible recovery
Patients should understand that erythema, swelling, crusting, and temporary color change can occur during healing.
Darker-skinned patients should also be prepared for the possibility of visible PIH and may need corrective concealers after the treated surface has re-epithelialized and the practitioner confirms that cosmetic products are safe to use.
Understanding the Trade-offs
Lighter skin does not mean complication-free treatment
Types I–II generally have less PIH risk, but they may develop pronounced or prolonged postoperative erythema.
They remain vulnerable to infection, delayed healing, scarring, acne or milia, and textural irregularities. Patient selection must therefore include general wound-healing and procedural risk assessment.
Er:YAG reduces thermal exposure but may change the treatment effect
Er:YAG can provide more controlled ablation and less collateral heat than traditional CO₂. However, a lower thermal profile may produce different degrees of tightening, coagulation, and remodeling.
The practitioner should select the modality based on the desired clinical endpoint, not pigment risk alone.
Conservative settings may require more treatment
Lower energy, reduced density, fewer passes, or fractional delivery may lower the risk of pigmentary injury, but they can also reduce the immediate treatment effect.
Patients may require multiple sessions or accept a more gradual improvement rather than undergoing a single aggressive procedure.
Pigment complications can be delayed
PIH may become evident during recovery, while hypopigmentation may appear much later.
Counseling should address both short-term and delayed pigmentary outcomes, including the possibility that hypopigmentation can be persistent.
Making the Right Choice for the Patient’s Goal
A defensible decision should combine Fitzpatrick type, pigmentary history, treatment indication, device characteristics, and the patient’s ability to follow aftercare.
- If your primary focus is maximum resurfacing for Types I–II: CO₂ or Er:YAG may be considered at appropriately selected high-energy settings, while still counseling about erythema, healing, and scarring risks.
- If your primary focus is treating lighter Type III skin: Use a cautious risk assessment that accounts for tanning, prior PIH, treatment depth, and whether fractional or staged treatment is more appropriate.
- If your primary focus is treating Types IV–VI: Prefer a conservative, lower-thermal approach—often Er:YAG or carefully adjusted fractional CO₂—along with a test spot, strict photoprotection, and explicit counseling about PIH and delayed hypopigmentation.
- If your primary focus is severe rhytids or scarring in darker skin: Proceed only when the expected benefit justifies the increased risk, and document test-spot findings, conservative parameters, and the patient’s informed consent.
- If your primary focus is minimizing pigmentary complications: Optimize sun avoidance, consider practitioner-directed pigment pre-treatment when appropriate, limit unnecessary thermal injury, and reassess before escalating treatment.
The safest resurfacing plan is the one that matches treatment intensity to both the patient’s pigmentary risk and the improvement they genuinely need.
Summary Table:
| Fitzpatrick Type | Risk Level | Recommended Approach | Key Considerations |
|---|---|---|---|
| I & II | Low | Standard CO2 or Er:YAG settings | Risk of erythema, scarring; still need aftercare |
| III (lighter) | Moderate | Conservative settings, consider fractional | Check tanning, prior PIH, adjust depth |
| IV-VI | High | Er:YAG or fractional CO2, test spot, staged treatment | High PIH risk, delayed hypopigmentation, strict photoprotection |
Elevate your practice with BELIS's advanced laser systems, including CO2 and Er:YAG devices, designed for safe and effective resurfacing across all skin types. Our professional-grade equipment and expert support help you deliver optimal results. Contact us today to learn how BELIS can enhance your clinic's offerings and patient satisfaction. Get in touch now.
Related Products
People Also Ask
- What is the technical principle behind CO2 Laser Fractional micro-perforations? Master Scar Revision Mechanics
- Why are professional laser systems, such as CO2 fractional or Erbium lasers, more effective for deep wrinkle reduction and dermal remodeling than topical anti-aging ingredients like retinoids, vitamin C, or peptides? Discover the targeted power of fractional lasers.
- What is the rationale for a double-pass technique with fractional CO2 lasers? Maximize Deep Collagen Remodeling
- What role does fractional CO2 laser equipment play in the treatment of SUI? Non-Surgical Stress Urinary Incontinence Care
- What is the purpose of manually extracting large cysts before CO2 fractional laser? Optimize Eyelid Milia En Plaque Care
